Protective effect of polydatin against bum-induced lung injury in rats

Respiratory Care

Volumn 59, Issue 9, 2014, Pages 1412-1421

  Li, Tao ^a   Cai, Shumin ^a   Zeng, Zhenhua ^a   Zhang, Junli ^a   Gao, Youguang ^a,c   Wang, Xingmin ^b   Chen, Zhongqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Department of Clinical Laboratory Maternal and Child Health Hospital of Liuzhou   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Extensive burn; Inflammation; Lung injury; Permeability; Polydatin

Indexed keywords

CASPASE 3; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; PICEID; PROTEIN BAX; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; BAX PROTEIN, RAT; BCL2L1 PROTEIN, RAT; GLUCOSIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; PROTEIN BCL X; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; HISTOLOGY; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; LUNG MICROVASCULAR PERMEABILITY ASSAY; LUNG WEIGHT; MALE; MEMBRANE PERMEABILITY; NONHUMAN; RAT; WESTERN BLOTTING; ACUTE LUNG INJURY; ANIMAL; APOPTOSIS; BLOOD; CAPILLARY PERMEABILITY; COMPLICATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; LEUKOCYTE COUNT; LUNG; METABOLISM; NEUTROPHIL; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY EDEMA; SPRAGUE DAWLEY RAT; SURVIVAL RATE; VASCULARIZATION;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; BURNS; CAPILLARY PERMEABILITY; CASPASE 3; DOWN-REGULATION; GLUCOSIDES; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTE COUNT; LUNG; MALE; NEUTROPHILS; ORGAN SIZE; PEROXIDASE; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919465462     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02831     Document Type: Article

References (46)

1. Maybauer MO, Rehberg S, Traber DL, Herndon DN, Maybauer DM. Pathophysiology of acute lung injury in severe burn and smoke inhalation injury. Anaesthesist 2009; 58(8): 805-812.
2. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest 2007; 131 (2): 554-562.
3. Turnage RH, Nwariaku F, Murphy J, Schulman C, Wright K, Yin H. Mechanisms of pulmonary microvascular dysfunction during severe burn injury. World J Surg 2002; 26(7): 848-853.
4. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122(8): 2731-2740.
5. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005; 11(1): 43-49.
6. Gokakin AK, Deveci K, Kurt A, Karakus BC, Duger C, Tuzcu M, et al. The protective effects of sildenafil in acute lung injury in a rat model of severe scald burn: a biochemical and histopathological study. Burns 2013; 39(6): 1193-1199.
7. Zhong WT, Wu YC, Xie XX, Zhou X, Wei MM, Soromou LW, et al. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-kappaB activation in acute lung injury mice. Fitoterapia 2013; 90: 132-139.
8. Chopra M, Reuben JS, Sharma AC. Acute lung injury: apoptosis and signaling mechanisms. Exp Biol Med (Maywood) 2009; 234(4): 361-371.
9. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Nor-bury WB, et al. Pathophysiologic response to severe burn injury. Ann Surg 2008; 248(3): 387-401.
10. Schmidt EP, Tuder RM. Role of apoptosis in amplifying inflammatory responses in lung diseases. J Cell Death 2010; 2010(3): 41-53.
11. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202(2): 145-156.
12. Galani V, Tatsaki E, Bai M, Kitsoulis P, Lekka M, Nakos G, et al. The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 2010; 206(3): 145-150.
13. Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007; 35(10): 2243-2250.
14. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7(1); 1-7.
15. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F, et al. Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury. Shock 2003; 20(4): 363-368.
16. Perl M, Lomas-Neira J, Chung CS, Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med 2008; 14(7-8): 465-475.
17. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5(14): 1317-1327.
18. Ferkol T, Cohn LA, Phillips TE, Smith A, Davis PB. Targeted delivery of antiprotease to the epithelial surface of human tracheal xenografts. Am J Respir Crit Care Med 2003; 167(10): 1374-1379.
19. Marko P, Layon AJ, Caruso L, Mozingo DW, Gabrielli A. Burn injuries. Curr Opin Anaesthesiol 2003; 16(2): 183-191.
20. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I, et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 2001; 163(3 Pt 1): 762-769.
21. Husari AW, Khayat A, Awdeh H, Hatoum H, Nasser M, Mroueh SM, et al. Activated protein C attenuates acute lung injury and apoptosis in a hyperoxic animal model. Shock 2010; 33(5): 467-472.
22. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
23. Li L, Wu W, Huang W, Hu G, Yuan W, Li W. NF-kappaB RNAi decreases the Bax/Bcl-2 ratio and inhibits TNF-alpha-induced apoptosis in human alveolar epithelial cells. Inflamm Res 2013; 62(4): 387-397.
24. Childs EW, Tharakan B, Hunter FA, Tinsley JH, Cao X. Apoptotic signaling induces hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 2007; 292(6): H3179-H3189.
25. Deng J, Liu W, Wang Y, Dong M, Zheng M, Liu J. Polydatin modulates Ca(2+) handling, excitation-contraction coupling and beta-adrenergic signaling in rat ventricular myocytes. J Mol Cell Cardiol 2012; 53(5): 646-656.
26. Wang X, Song R, Bian HN, Brunk UT, Zhao M, Zhao KS. Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock. Am J Physiol Regul Integr Comp Physiol 2012; 302(7): R805-R814.
27. Jiang X, Liu W, Deng J, Lan L, Xue X, Zhang C, et al. Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca leak by reducing oxidative modification of ryanodine receptors. Free Radic Biol Med 2013; 60C: 292-299.
28. Zhao KS, Jin C, Huang X, Liu J, Yan WS, Huang Q, et al. The mechanism of Polydatin in shock treatment. Clin Hemorheol Micro-circ 2003; 29(3-4): 211-217.
29. Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation, 2012; 35(1): 240-248.
30. Cheng Y, Zhang HT, Sun L, Guo S, Ouyang S, Zhang Y, et al. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res 2006; 1110(1): 193-200.
31. Ravagnan G, De Filippis A, Carteni M, De Maria S, Cozza V, Petrazzuolo M, et al. Polydatin, a natural precursor of resveratrol, induces beta-defensin production and reduces inflammatory response. Inflammation 2013; 36(1); 26-34.
32. Wang X, Song R, Chen Y, Zhao M, Zhao KS. Polydatin-a new mitochondria protector for acute severe hemorrhagic shock treatment. Expert Opin Investig Drugs 2013; 22(2): 169-179.
33. Li XH, Gong X, Zhang L, Jiang R, Li HZ, Wu MJ, et al. Protective effects of polydatin on septic lung injury in mice via upregulation of HO-I. Mediators Inflamm 2013; 2013: 354087.
34. Walker HL, Mason AJ. A standard animal burn. J Trauma 1968; 8(6): 1049-1051.
35. Petito CK, Pulsinelli WA, Jacobson G, Plum F. Edema and vascular permeability in cerebral ischemia: comparison between ischemic neuronal damage and infarction. J Neuropathol Exp Neurol 1982; 41 (4): 423-436.
36. Saria A, Lundberg JM. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 1983; 8(1): 41-49.
37. Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, et al. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol 2007; 50(1): 41.
38. Qiu X, Li H, Tang H, Jin Y, Li W, Sun Y, et al. Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice-Int Immunopharmacol 2011; 11 (12): 2130-2137.
39. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet, 2007; 369(9572): 1553-1564.
40. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295(3): L379-L399.
41. Fine A, Janssen-Heininger Y, Soultanakis RP, Swisher SG, Uhal BD. Apoptosis in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol 2000; 279(3): L423-L427.
42. Matthay MA. Conference summary: acute lung injury. Chest 1999; 116(1 Suppl): 119S-126S.
43. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998; 95(25): 14681-14686.
44. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem 2011; 286(1): 491-501.
45. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 2006; 57(5): 545-553.
46. Kaufmann SH, Lee SH, Meng XW, Loegering DA, Kottke TJ, Hen-zing AJ, et al. Apoptosis-associated caspase activation assays. Methods 2008; 44(3): 262-272.